$CRWDNeutralLow

GANDHI SAMEER K sold $86K of CRWD

GANDHI SAMEER K sold 112 shares of CrowdStrike Holdings, Inc. (CRWD) at $767.55 on 2026-06-01 under a Rule 10b5-1 trading plan.

6/10
3/10
Low
Neutral
Filed June 3; sale executed June 1 under a 10b5-1 plan.
Neutral—insider sale disclosed without new operational or financial catalyst.

Insider selling is disclosed, but the pre-arranged 10b5-1 structure reduces signal strength versus discretionary sales.

CrowdStrike director Sameer K Gandhi sold $85,965 of CRWD shares via a Rule 10b5-1 plan disclosed on SEC Form 4.

Likely limited near-term impact; any effect is more sentiment/positioning than fundamentals.

Background

SEC Form 4 reports insider transactions; Rule 10b5-1 sales are pre-planned to reduce insider-trading concerns.

Why it matters

This disclosure updates the record of insider activity but does not introduce new company fundamentals (no earnings, guidance, deal, or regulatory action).

Market relevance

Traders may note the sale for sentiment/positioning, but the 10b5-1 framing makes it less likely to drive a sustained price move.

Market effects

Minimal; this is company-specific insider transaction disclosure, not a sector-wide catalyst.

None expected beyond routine sentiment around a US mega-cap software name.

None expected; disclosure is US SEC Form 4 with no new global event.

Alternative perspectives

Even with 10b5-1, repeated insider selling can coincide with management’s risk management or diversification, potentially weighing on sentiment.

The sale is small relative to typical insider holdings and is explicitly pre-arranged, so traders may overreact if they treat it like discretionary bearish news.

Key entities

  • CrowdStrike Holdings, Inc.

    Subject of the SEC Form 4 insider sale by a director under a Rule 10b5-1 plan.

  • GANDHI SAMEER K

    Director who sold 112 shares at $767.55/share on June 1, 2026.

Related articles

$CRWDMed

Weakness May Be an Opportunity for CrowdStrike Stock

CrowdStrike said demand for its Falcon platform and broader security offerings remains strong as cybersecurity spending grows, including amid AI adoption, according to management. The company raised full-year ARR guidance to $6.53B–$6.56B and increased revenue and earnings guidance. Analysts: 34 “Strong Buy,” 3 “Moderate Buy,” 11 “Hold,” 2 “Strong Sell” (consensus “Moderate Buy”); mean target $723.74 and high $825.

$ZSMedAI 9/10

Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure

Zscaler shares fell more than 31% after fiscal Q3 2026 results, despite revenue of $850M+ (+25% YoY vs. $835M est.) and adjusted EPS of $1.08 (+28% YoY vs. $1.01 est.). The company raised full-year revenue growth to 24.6%–24.7% but cut its free-cash-flow margin outlook (midpoint 26.75% to 23.1%) and guided 16%–17% ARR growth next year. CrowdStrike slipped about 7% after fiscal Q1 2027 beats and a raise; revenue was $1.39B (+26% YoY), EPS $1.10 (+51% YoY), and net new ARR growth guidance increase

$CRWDLow

Rosenblatt Lifts PT on CrowdStrike (CRWD) Following “Outstanding” Q1

Rosenblatt raised its CrowdStrike (CRWD) price target to $825 from $640 and kept a Buy rating after what it called an “outstanding” fiscal Q1. The firm said shares fell about 11% after hours, attributing it to profit taking after an ~87% post-earnings rise, and cited the “Mythos moment” and Falcon’s role in AI cybersecurity. Wedbush also raised its target to $720 from $700, maintaining Outperform.

$CRWDLow

Is CrowdStrike Stock a Buy on the Dip?

CrowdStrike shares fell after fiscal Q1 results, despite the company raising its full-year ARR growth outlook to 27%–29% from 23%–24%, according to the report. Ending ARR rose 24% to $5.51B and net new ARR 32% to $256M. Revenue grew 26% to $1.39B; adjusted EPS rose 51% to $1.10. Fiscal 2027 revenue guidance was $5.915B–$5.959B and adjusted EPS $4.88–$4.96.